Rc. Thompson et al., THE MANAGEMENT OF PATIENTS WITH ARTERIOVENOUS-MALFORMATIONS AND ASSOCIATED INTRACRANIAL ANEURYSMS, Neurosurgery, 43(2), 1998, pp. 202-211
OBJECTIVE: Few published studies have focused specifically on the uniq
ue management issues encountered in treating patients with arterioveno
us malformations (AVMs) and associated intracranial aneurysms. The pri
mary objective of this study was to retrospectively review the clinica
l and radiographic features of these patients. METHODS: Medical record
s of all patients seen at Stanford University Hospital between 1988 an
d 1996 with a diagnosis of AVMs were retrospectively reviewed. Aneurys
ms were identified by conventional angiography and characterized by si
ze, number, and location relative to the AVMs. AVMs were graded accord
ing to the Spetzler-Martin scale. Odds ratios were calculated for the
risk of intracranial hemorrhage. Variables included age, sex, number o
f aneurysms, and AVM grade. RESULTS: Forty-five of 600 patients (7.5%)
were identified as having coexisting intracranial aneurysms. All 45 p
atients had high-flow malformations, and 58% had AVMs of Spetzler-Mart
in Grade IV or higher. A majority of patients had multiple aneurysms.
There was a statistically significant increase in AVM hemorrhage in fe
male patients (odds ratio, 8.53 [1.87-38.98]; P < 0.005). There was no
statistically significant correlation between the development of hemo
rrhage and either age, AVM grade, or the number of aneurysms. Twenty-t
hree patients (51%) presented with intracranial hemorrhage: bleeding o
ccurred from the AVMs in 15 and from ruptured aneurysms in 5, and the
source of the bleeding could not be determined in 3. Overall, nine pat
ients (20%) bled from ruptured aneurysms: five at presentation, two du
ring or within 3 weeks of AVM treatment, and two from new aneurysms. T
wo of these nine patients died as a direct result of aneurysmal subara
chnoid hemorrhage. Five patients (11%) developed new aneurysms. CONCLU
SION: Aneurysms associated with AVMs are at risk for rupture before, d
uring, and immediately after treatment of the AVMs. New aneurysms may
arise in patients with high-flow AVMs. The risk of intracranial hemorr
hage from either source is higher in female patients. To reduce the co
mplications of intracranial hemorrhage in these patients, we recommend
a management protocol designed to treat the aneurysms by surgical or
endovascular means before administering definitive therapy for the AVM
s. Meticulous intraoperative blood pressure control and fluid manageme
nt during aneurysm surgery is critical to avoid hemorrhage from the AV
Ms.